Digital mental health specialist Woebot raises $90mInvestments in digital health firms are running high at the moment, and a $90 million round for four-year-old Share XDigital mental health specialist Woebot raises $90mhttps://pharmaphorum.com/news/digital-mental-health-specialist-woebot-raises-90m/
Dopavision raises €12m for DTx to tackle myopia epidemicDigital therapeutics (DTx) startup Dopavision has raised funding to develop its lead product, an app designed to slow Share XDopavision raises €12m for DTx to tackle myopia epidemichttps://pharmaphorum.com/news/dopavision-raises-e12m-for-dtx-to-tackle-myopia-epidemic/
Digital health investment has skyrocketed; now expect consolidationA record $14.7 billion in investments was injected into US digital health companies in the first half of Share XDigital health investment has skyrocketed; now expect consolidationhttps://pharmaphorum.com/news/digital-health-investment-has-skyrocketed-now-expect-consolidation/
DTx company Pear shapes public listing with $1.6bn SPAC mergerDigital health company Pear Therapeutics has foregone the traditional initial public offering (IPO) route to a stock exchange Share XDTx company Pear shapes public listing with $1.6bn SPAC mergerhttps://pharmaphorum.com/news/dtx-company-pear-shapes-public-listing-with-1-6bn-spac-merger/
Ambrx tries another IPO as it chases down HER2 rivalsCalifornia biotech Ambrx Biopharma is hoping to raise $126 million from a listing on the New York Stock Share XAmbrx tries another IPO as it chases down HER2 rivalshttps://pharmaphorum.com/news/ambrx-tries-another-ipo-as-it-chases-down-her2-rivals/
Dermavant raises $200m to ease launch of Otezla rival tapinarofDermavant is in line to make some big payments to GlaxoSmithKline if its topical psoriasis drug tapinarof reaches Share XDermavant raises $200m to ease launch of Otezla rival tapinarofhttps://pharmaphorum.com/news/dermavant-raises-200m-to-ease-launch-of-otezla-rival-tapinarof/
Babylon Health may go public via blank cheque company merger; reportDigital health player Babylon Health is exploring a merger with a so-called ‘blank cheque’ company as a route Share XBabylon Health may go public via blank cheque company merger; reporthttps://pharmaphorum.com/news/babylon-health-may-go-public-via-blank-cheque-company-merger-report/
Bayer backs Ada Health’s symptom checker app in $90m financingAda Health has received another endorsement for its app to help patients diagnose conditions from symptoms, raising an Share XBayer backs Ada Health’s symptom checker app in $90m financinghttps://pharmaphorum.com/news/bayer-backs-ada-healths-symptom-checker-in-90m-financing/
Akili raises $110m to build its digital therapeutics pipelineDigital health player Akili has raised $110 million fourth-round funding, backed by a number of pharma groups, as Share XAkili raises $110m to build its digital therapeutics pipelinehttps://pharmaphorum.com/news/akili-raises-110m-to-build-its-digital-therapeutics-pipeline/
